We’re told an antiviral drug for COVID-19 is as far off as next year. As a longtime blood donor, it occurred to me that the antibodies people have developed over time after successfully fighting off an illness might be shared with those who receive a transfusion. Is it possible this might be a solution for those most vulnerable in the interim?
— William Ahrens
Have something on your mind? Send to firstname.lastname@example.org or click here to submit via any web browser. Letters under 200 words have the best chance of being published. Writers should disclose any personal or professional connections with the subjects of their letters. Letters are edited for accuracy, clarity and length.